how many people use glp-1 drugs Just Americans are taking GLP-1s now GLP-1 use: More people without

WangXCaiCLvWChenKLiJLiaoKet al

By modulating the expression of growth factors and antioxidant enzymes, the peptide accelerates tissue repair processes

Researchers have reported the potency of IGF-1 LR3 peptide to be as much as 3x more than that of IGF-1 (1) , holding a potentially much greater half-life: roughly 20 to 30 hours, compared to the original IGF-1, which has a reported approximate 12 to 15 hours of half-life

The SURPASS-CVOT trial is an ongoing phase 3 cardiovascular outcomes trial designed to evaluate the non-inferiority and potential superiority of tirzepatide compared to dulaglutide in cardiovascular outcomes [88,89]